September 3rd, 2020

A CS Warrior on the Facebook Chondrosarcoma Support Group entered a new Phase 2 clinical trial yesterday specifically for unresectable and metastatic conventional CS that combines a histone deacetylase inhibitor Belinostat (FDA approved for a type…

September 2nd, 2020

In September, we honor the gold ribbon in recognition of Childhood Cancer Awareness Month! ✨

Did you know cancer is the second leading cause of death in children under the age of 15? In 2020, approximately 11,000 children ages 1-14 will be…

Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

clinicaltrials.gov

Brief Summary:
This phase II trial studies how well belinostat and SGI-110…

August 31st, 2020

To view the video on YouTube, click here

August 29th, 2020

Schwartz Hunts for Predictive Biomarkers in Soft Tissue Sarcoma

Gary K. Schwartz, MD, highlights research that is being done with regard to genomic signatures in sarcoma, challenges faced with immunotherapy, and where the field is headed.

Gary K….

August 16th, 2020

Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency

Abstract

One of the crucial challenges in the clinical management of cancer is resistance to chemotherapeutics. Multidrug resistance (MDR) has been intensively studied,…

Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma
Warren Chow, MD1; Paul Frankel, PhD2; Chris Ruel, PhD2; Dejka M. Araujo, MD3; Mohammed Milhem, MBBS4; Scott Okuno, MD5; Lee…

August 12th, 2020

A new article Treating Chondrosarcoma with Urgency and Compassion has just been posted on the Chondrosarcoma Web Site (www.csfshayna.org). You can find the article on the Commentaries page…

August 10th, 2020

Please check out our Web Site www.csfshayna.org to get acquainted with our board of directors and staff for the Chondrosarcoma Foundation.

July 31st, 2020

Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas

MICHAEL J. NATHENSON, ANTHONY P. CONLEY, b EDWARD SAUSVILLE,

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;…